ArticleTargeted oncology2021

A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer.

Kathleen N Moore et al.PubMed ↗Publisher ↗

No numbers read from the abstract.